Psoriasis: pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems.
Abstrak
Psoriasis is a chronic autoimmune skin disorder triggered by either genetic factors, environmental factors, life style, or a combination thereof. Clinical investigations have identified pathogenesis, such as T cell and cytokine-mediated, genetic disposition, antimicrobial peptides, lipocalin-2, galectin-3, vaspin, fractalkine, and human neutrophil peptides in the progression of psoriasis. In addition to traditional therapies, newer therapeutics, including phosphodiesterase type 4 (PDE4) inhibitors, Janus kinase (JAK) inhibitors, monoclonal antibodies (mAbs), gene therapy, anti-T cell therapy, and phytoconstituents have been explored. In this review, we highlight nanotechnology-related developments for psoriasis treatment, including patented delivery systems and therapeutics currently in clinical trials.
Topik & Kata Kunci
Penulis (6)
V. Rapalli
Tejashree Waghule
Srividya Gorantla
S. Dubey
R. Saha
Gautam Singhvi
Akses Cepat
PDF tidak tersedia langsung
Cek di sumber asli →- Tahun Terbit
- 2020
- Bahasa
- en
- Total Sitasi
- 84×
- Sumber Database
- Semantic Scholar
- DOI
- 10.1016/j.drudis.2020.09.023
- Akses
- Open Access ✓